Article Type
Review
Published
This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.
Medications for treating and technology for managing diabetes have advanced significantly in recent years. We now have multiple therapeutic agents that not only reduce glycaemia but also cardiovascular and renal disease. Advances in continuous glucose monitoring have been game-changers for patients and their caregivers, though management of hypoglycaemia remains a concern that necessitates focused education and prevention efforts. Patients who develop gestational diabetes require specific care during and after pregnancy, as do patients with diabetes who have comorbid peripheral neuropathy and/or overweight or obesity. Moving forward, we will likely see treatment paradigms shift toward preference for medications that have beneficial effects beyond glycaemic control and better use of technology to assist with efficacy and safety parameters germane to diabetes management.
Review
This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.
Review
This narrative review provides the most up-to-date information regarding existing and new pharmacotherapy for the management of chronic kidney disease amongst people with diabetes, specifically type 2 diabetes.
Review
With the prevalence of type 2 diabetes increasing, this article discusses how it is essential that healthcare professionals assess how their patients’ current diabetes treatment is being managed to avoid further weight gain in those who are already overweight or obese.
Review
This narrative review summarizes the current state of information available regarding the treatment of gestational diabetes mellitus.
Review
This narrative review discusses the pathophysiological mechanisms that are currently believed to lead to diabetic peripheral neuropathy (DPN), DPN screening and diagnosis, methods of prevention, and treatment options to address DPN symptoms and complications.
Review
In this review, the definitions and risk factors for hypoglycaemia will be briefly discussed and an in-depth review of the management for a conscious or unconscious patient in the outpatient and inpatient settings is provided.
Review
This narrative review seeks to investigate the efficacy and safety of continuous glucose monitoring for the management of diabetes